Relationship between time of exposure of laryngopharyngeal reflux and gene expression in laryngeal fibroblasts

Annals of Otology, Rhinology and Laryngology

Volumn 115, Issue 10, 2006, Pages 775-783

  Ylitalo, Riitta ^a,b,d   Thibeault, Susan L ^c  

^a KAROLINSKA INSTITUTE   (Sweden)

^b UMEÅ UNIVERSITY   (Sweden)

^c UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^d KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Cell culture; Decorin; Extraesophageal reflux; Gene expression; Growth factor; Matrix metalloproteinase; Pepsin

Indexed keywords

ACID; ACTIVATING TRANSCRIPTION FACTOR 3; CONNECTIVE TISSUE GROWTH FACTOR; DECORIN; EARLY GROWTH RESPONSE FACTOR 1; FIBROBLAST GROWTH FACTOR 2; GELATINASE A; INTERSTITIAL COLLAGENASE; MESSENGER RNA; PEPSIN A; TRANSFORMING GROWTH FACTOR BETA1; VASCULOTROPIN;

ARTICLE; CELL CULTURE; CELL PH; FIBROBLAST; GENE EXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; HUMAN TISSUE; LARYNGOPHARYNGEAL REFLUX; LARYNX; MALE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; REFLUX ESOPHAGITIS; SCHOOL CHILD; VOCAL CORD;

EID: 33750048749     PISSN: 00034894     EISSN: None     Source Type: Journal    
DOI: 10.1177/000348940611501011     Document Type: Article

References (29)

1. DeMeester TR, Johnson LF, Joseph GJ, Toscano MS, Hall AW, Skinner DB. Patterns of gastroesophageal reflux in health and disease. Ann Surg 1976;184:459-70.
2. Sifrim D. Acid, weakly acidic and non-acid gastro-oesophageal reflux: differences, prevalence and clinical relevance. Eur J Gastroenterol Hepatol 2004;16:823-30.
3. Tobey NA, Hosseini SS, Caymaz-Bor C, Wyatt HR, Orlando GS, Orlando RC. The role of pepsin in acid injury to esophageal epithelium. Am J Gastroenterol 2001;96:3062-70.
4. Ylitalo R, Lindestad PA, Ramel S. Symptoms, laryngeal findings, and 24-hour pH monitoring in patients with suspected gastroesophagopharyngeal reflux. Laryngoscope 2001;111:1735-41.
5. Noordzij JP, Khidr A, Desper E, Meek RB, Reibel JF, Levine PA. Correlation of pH probe-measured laryngopharyngeal reflux with symptoms and signs of reflux laryngitis. Laryngoscope 2002;112:2192-5.
6. Powitzky ES, Khaitan L, Garrett CG, Richards WO, Courey M. Symptoms, quality of life, videolaryngoscopy, and twenty-four-hour triple-probe pH monitoring in patients with typical and extraesophageal reflux. Ann Otol Rhinol Laryngol 2003;112:859-65.
7. Hill RK, Simpson CB, Velazquez R, Larson N. Pachydermia is not diagnostic of active laryngopharyngeal reflux disease. Laryngoscope 2004;114:1557-61.
8. Vaezi MF, Richter JE, Stasney CR, et al. Treatment of chronic posterior laryngitis with esomeprazole. Laryngoscope 2006;116:254-60.
9. Steward DL, Wilson KM, Kelly DH, et al. Proton pump inhibitor therapy for chronic laryngo-pharyngitis: a randomized placebo-control trial. Otolaryngol Head Neck Surg 2004;131:342-50.
10. Tokashiki R, Nakamura K, Watanabe Y, Yamaguchi H, Suzuki M. The relationship between esophagoscopic findings and total acid reflux time below pH 4 and pH 5 in the upper esophagus in patients with laryngopharyngeal reflux disease (LPRD). Auris Nasus Larynx 2005;32:265-8.
11. Ylitalo R, Baugh A, Li W, Thibeault S. The effect of acid and pepsin on gene expression in laryngeal fibroblasts. Ann Otol Rhinol Laryngol 2004;113:866-71.
12. Vaezi MF, Singh S, Richter JE. Role of acid and duodenogastric reflux in esophageal mucosal injury: a review of animal and human studies. Gastroenterology 1995;108:1897-907.
13. Lillemoe KD, Johnson LF, Harmon JW. Role of the components of the gastroduodenal contents in experimental acid esophagitis. Surgery 1982;92:276-84.
14. Johnston N, Bulmer D, Gill GA, et al. Cell biology of laryngeal epithelial defenses in health and disease: further studies. Ann Otol Rhinol Laryngol 2003;112:481-91.
15. Hickson C, Simpson CB, Falcon R. Laryngeal pseudosulcus as a predictor of laryngopharyngeal reflux. Laryngoscope 2001;111:1742-5.
16. Belafsky PC, Postma GN, Koufman JA. The association between laryngeal pseudosulcus and laryngopharyngeal reflux. Otolaryngol Head Neck Surg 2002;126:649-52.
17. Merati AL, Lim HJ, Ulualp SO, Toohill RJ. Meta-analysis of upper probe measurements in normal subjects and patients with laryngopharyngeal reflux. Ann Otol Rhinol Laryngol 2005;114:177-82.
18. Koufman JA. The otolaryngologic manifestations of gastroesophageal reflux disease (GERD): a clinical investigation of 225 patients using ambulatory 24-hour pH monitoring and an experimental investigation of the role of acid and pepsin in the development of laryngeal injury. Laryngoscope 1991;101 (suppl 53).
19. Smit CF, Tan J, Devriese PP, Mathus-Vliegen LMH, Brandsen M, Schouwenburg PF. Ambulatory pH measurements at the upper esophageal sphincter. Laryngoscope 1998;108:299-302.
20. Bove M, Ruth M, Cange L, Mansson I. 24-H pharyngeal pH monitoring in healthy volunteers: a normative study. Scand J Gastroenterol 2000;35:234-41.
21. Oelschlager BK, Quiroga E, Isch JA, Cuenca-Abente F. Gastroesophageal and pharyngeal reflux detection using impedance and 24-hour pH monitoring in asymptomatic subjects: defining the normal environment. J Gastrointest Surg 2006;10:54-62.
22. Ulualp SO, Roland PS, Toohill RJ, Shaker R. Prevalence of gastroesophageal acid reflux events: an evidence-based systematic review. Am J Otolaryngol 2005;26:239-44.
23. Duggan SP, Gallagher WM, Fox EJP, Abdel-Latif MM, Reynolds JV, Kelleher D. Low pH induces co-ordinate regulation of gene expression in oesophageal cells. Carcinogenesis 2006;27:319-27.
24. Adhami T, Goldblum JR, Richter JE, Vaezi MF. The role of gastric and duodenal agents in laryngeal injury: an experimental canine model. Am J Gastroenterol 2004;99:2098-106.
25. Sohn YD, Lim HJ, Hwang KC, et al. A novel recombinant basic fibroblast growth factor and its secretion. Biochem Biophys Res Common 2001;284:931-6.
26. Andersson O, Ylitalo R, Finizia C, Bove M, Ruth M. Pharyngeal reflux episodes at pH 5 in healthy volunteers. Scand J Gastroenterol 2006;41:138-43.
27. Lord RVN, Park JM, Wickramasinghe K, et al. Vascular endothelial growth factor and basic fibroblast growth factor expression in esophageal adenocarcinoma and Barrett esophagus. J Thorac Cardiovasc Surg 2003;125:246-53.
28. Sarioglu S, Ozer E, Kirimca F, Siş B, Pabuccuoglu U. Matrix metalloproteinase-2 expression in laryngeal preneoplastic and neoplastic lesions. Pathol Res Pract 2001;197:483-6.
29. Johnston N, Dettmar PW, Lively MO, et al. Effect of pepsin on laryngeal stress protein (Sep70, Sep53, and Hsp70) response: role in laryngopharyngeal reflux disease. Ann Otol Rhinol Laryngol 2006;115:47-58.